Friday, 6 November 2026European Markets

SOLVAC NOM(RETAIL) And SOLVAY Have A High Dividend Yield And Return On Equity In The Chemicals Industry.

Loading stream...

(VIANEWS) - SOLVAC NOM(RETAIL) (SOLV.BR) is among this list of stock assets with the highest dividend rate and return on equity on the Chemicals industry.

Financial Asset Price Forward Dividend Yield Return on Equity
SOLVAC NOM(RETAIL) (SOLV.BR) €100.00 7.03% 4.21%
SOLVAY (SOLB.BR) €34.79 4.68% 0.47%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SOLVAC NOM(RETAIL) (SOLV.BR)

7.03% Forward Dividend Yield and 4.21% Return On Equity

Solvac S.A. operates as an advanced materials and specialty chemicals company in Belgium. It offers specialty polymers, composite materials, soda ash, peroxides, silica, and coatis. The company was incorporated in 1983 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, SOLVAC NOM(RETAIL) has a trailing twelve months EPS of €5.96.

PE Ratio

SOLVAC NOM(RETAIL) has a trailing twelve months price to earnings ratio of 16.78. Meaning, the purchaser of the share is investing €16.78 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.21%.

More news about SOLVAC NOM(RETAIL).

2. SOLVAY (SOLB.BR)

4.68% Forward Dividend Yield and 0.47% Return On Equity

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, SOLVAY has a trailing twelve months EPS of €0.13.

PE Ratio

SOLVAY has a trailing twelve months price to earnings ratio of 267.62. Meaning, the purchaser of the share is investing €267.62 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.47%.

Volume

Today's last reported volume for SOLVAY is 70824 which is 63% below its average volume of 191421.

Moving Average

SOLVAY's worth is above its 50-day moving average of €31.97 and way above its 200-day moving average of €29.40.

Sales Growth

SOLVAY's sales growth is negative 62.1% for the present quarter and negative 61% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.8%, now sitting on 5.34B for the twelve trailing months.

More news about SOLVAY.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com